首页> 外文期刊>Nature >E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells
【24h】

E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells

机译:E2f1-3从祖细胞中的活化剂切换到分化细胞中的阻遏物

获取原文
获取原文并翻译 | 示例
           

摘要

In the established model of mammalian cell cycle control, the retinoblastoma protein (Rb) functions to restrict cells from entering S phase by binding and sequestering E2f activators (E2f1, E2f2 and E2f3), which are invariably portrayed as the ultimate effectors of a transcriptional program that commit cells to enter and progress through S phase. Using a panel of tissue-specific cre-transgenic mice and conditional E2f alleles we examined the effects of E2f1, E2f2 and E2f3 triple deficiency in murine embryonic stem cells, embryos and small intestines. We show that in normal dividing progenitor cells E2f1-3 function as transcriptional activators, but contrary to the current view, are dispensable for cell division and instead are necessary for cell survival. In differentiating cells E2f1-3 function in a complex with Rb as repressors to silence E2f targets and facilitate exit from the cell cycle. The inactivation of Rb in differentiating cells resulted in a switch of E2f1-3 from repressors to activators, leading to the superactivation of E2f responsive targets and ectopic cell divisions. Loss of E2f1-3 completely suppressed these phenotypes caused by Rb deficiency. This work contextualizes the activator versus repressor functions of E2f1-3 in vivo, revealing distinct roles in dividing versus differentiating cells and in normal versus cancer-like cell cycles.
机译:在已建立的哺乳动物细胞周期控制模型中,成视网膜细胞瘤蛋白(Rb)通过结合和螯合E2f激活剂(E2f1,E2f2和E2f3)来限制细胞进入S期,这总是被描述为转录程序的最终效应子使细胞进入并进入S期。使用一组组织特异性cre转基因小鼠和条件E2f等位基因,我们研究了E2f1,E2f2和E2f3三重缺乏对小鼠胚胎干细胞,胚胎和小肠的影响。我们显示,在正常分裂的祖细胞中,E2f1-3发挥转录激活剂的作用,但与当前观点相反,对于细胞分裂是必不可少的,而对于细胞存活是必不可少的。在分化细胞中,E2f1-3与Rb一起作为阻遏物发挥功能,使E2f目标沉默并促进细胞周期的退出。 Rb在分化细胞中的失活导致E2f1-3从阻遏物转变为激活物,从而导致E2f响应靶标和异位细胞分裂的超活化。 E2f1-3的丧失完全抑制了由Rb缺乏引起的这些表型。这项工作将E2f1-3在体内的激活子和阻遏子功能结合起来,揭示了在分化与分化细胞以及正常与癌样细胞周期中的不同作用。

著录项

  • 来源
    《Nature》 |2009年第7275期|930-934|共5页
  • 作者单位

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA Division of Pediatric Hematology/Oncology, Children's Hospital Boston Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA;

    Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

    Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 ORE, UK;

    The Beatson Institute for Cancer Research, Glasgow G61 1BD, UK;

    Toronto Western Research Institute, University Health Network, Departments of Ophthalmology and Visual Science, and Laboratory Medicine and Pathobiology, University of Toronto, Ontario M5T 2S8, Canada;

    Toronto Western Research Institute, University Health Network, Departments of Ophthalmology and Visual Science, and Laboratory Medicine and Pathobiology, University of Toronto, Ontario M5T 2S8, Canada;

    Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;

    Department of Zoology, Miami University, Oxford, Ohio 45056, USA;

    Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, USA;

    Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine Ohio 43210, USA Department of Molecular Genetics, College of Biological Sciences Ohio 43210, USA Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio 43210, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号